In this study, the incidence rate of esophagus cancer was estimated by the capture-recapture method and log-linear models. The mean age of all subjects was 66.68 ± 13.23 years (67.60 ± 12.91 for men and 65.48 ± 13.58 for women). The age distribution does not show the difference between men and women and slightly higher than the average age reported by studies conducted in other parts of Iran that reported average age 58 - 65 years for esophagus cancer (
17-
19), but reported average age in the study conducted in Tehran metropolitan was 70.40 (70.5 for men and 70.3 for women) that is slightly higher than present study (
7). Male to female ratio was 1.29 that is consistent with international and regional reports (
2,
7,
20).
In log-linear analysis, the model where sources pathology and hospital records are dependent and independent of the source death certificates was selected. In this study, we select the best model using AIC, BIC and G
2 statistics. The description of this relationship in situations as to what happens in society seems also logical, especially about dependencies between pathology reports and hospital records. The reported incidence rate of esophagus cancer based on population based cancer registry in Ardabil province, after removing duplicate cases between pathology reports, hospital records and death certificates, for 2006 and 2008 years was 18.77 per 100,000 and 18.51 per 100,000 populations, respectively. Also the registered incidence rate in men and women, after removing the duplicates between sources, in 2006 was 21.08 and 16.33 per 100,000 populations, and in 2008 was 19.95 and 16.99 per 100,000 populations, respectively. Babaei et al. reported esophagus cancer incidence as 19.5 per 100,000 populations during 2004 to 2006 years (
21). This result is consistent with the registered incidence rate in this study. The estimated incidence rate of esophagus cancer in log-linear analysis, with consideration of the number of cases not registered in any sources, for 2006 and 2008 was 49.71 (95% CI: 37.79 - 69.12) per 100,000 populations and 53.87(95% CI: 38.97 - 79.64) per 100,000 populations, respectively. In a study conducted in Tehran, the estimated incidence of esophagus cancer was reported 10.5 per 100,000 populations, respectively (
7). Also the estimated incidence rate reported by Globocan for man and woman in Iran was 9 and 8 per 100,000 populations, respectively (
22). But this estimation is for the country in general, while in Iran, most northern and northwestern areas are at high risk for esophagus cancer. Also the central and western provinces are at medium risk and the southern regions are at a low risk (
23). As Ardabil is located in northwestern of Iran and has the highest incidence of esophagus cancer in Iran (
23), the higher incidence in this study seems reasonable. The estimated completeness in log-linear analysis for 2006 and 2008 was 37.76% and 34.36%, respectively. The completeness of cancer registries in our study is much lower than other countries that reported 96 % to 99.6% for all types of cancers in overall (
8,
24,
25) and also for gastrointestinal cancers in Canada was reported 95.83% (
8). The completeness of esophagus cancer registry in Tehran was reported 27.3% (
7) and is consistent with results of our study. Thus the results of our study confirmed that the quality of cancer registry in Iran is inappropriate and needs more attention to amplify its quality. Some strategies such as use of national code of patients instead of name and surname, universal online registry using electronic health records, training cancer registry staffs and also training of death registry staffs about the immediate or underlying cause of death must be used to improve the quality of the cancer registry system.